alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 72, Number 7 (Thursday, January 11, 2007)]
[Notices]
[Pages 1335-1336]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-69]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel CA 07-503, ``Advanced Technology Radiation Therapy Clinical 
Trials Support (ATC) (U24).''
    Name: March 5, 2007.
    Time: 12 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6130 Executive Blvd., 
Conference Room D, Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Kenneth L. Bielat, PhD, Scientific Review 
Administrator, Division of Extramural Activities, National Cancer

[[Page 1336]]

Institute, 6116 Executive Boulevard, Room 7147, Bethesda, MD 20892, 
(301) 496-7576, <a href="/cdn-cgi/l/email-protection#5d3f3438313c29363c1d303c343173333435733a322b"><span class="__cf_email__" data-cfemail="76141f131a17021d17361b171f1a58181f1e58111900">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: January 4, 2007,
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-69 Filed 1-10-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
1

                                                                   EXHIBIT 23.3






                       Consent of Independent Accountants



We  hereby  consent  to  the   incorporation  by  reference  in  the  Prospectus
constituting part of this Registration Statement on Form S-2 of our report dated
August 1, 1997  relating to the  consolidated  financial  statements  of Curtice
Burns Foods, Inc. (Successor Company), appearing on page 21 of the Annual Report
on Form 10-K of Curtice  Burns Foods,  Inc. for the year ended June 28, 1997. We
also  consent  to the  application  of  such  report  to the  related  Financial
Statement  Schedule  for the fiscal  years ended June 28, 1997 and June 29, 1996
and the period from November 4, 1994 to June 25, 1995 listed under Item 14(a) of
Curtice  Burns Foods,  Inc.'s Annual Report on Form 10-K for the year ended June
28, 1997 when such schedule is read in conjunction with the financial statements
referred to in our report.  The audits  referred to in such report also included
this Financial Statement Schedule.  We also consent to the reference to us under
the heading "Experts" in such Prospectus.



/s/ Price Waterhouse LLP
PRICE WATERHOUSE LLP

Rochester, New York
September 16, 1997
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Overseas Private Investment Corporation

# Time and Date:

Thursday, July 17, 2008, 10 a.m. (Open Portion). 10:15 a.m. (Closed Portion). 

# Place:

Offices of the Corporation, Twelfth Floor Board Room, 1100 New York Avenue, NW., Washington, DC. 

# Status:

Meeting Open to the Public from 10 a.m. to 10:15 a.m. Closed portion will commence at 10:15 a.m. (approx.) 

# Matters to be Considered:

1. President's Report. 

2. Approval of April 17, 2008 Minutes (Open Portion). 

# Further Matters to be Considered:

(Closed to the Public 10:15 a.m.) 

1. Report from Audit Committee. 

2. Finance Project—Jordan. 

3. Finance Project—Egypt. 

4. Finance and Insurance Project— The Republic of Togo. 

5. Finance Project—Russia. 

6. Finance Project—Global. 

7. Insurance Project—Jordan. 

8. Finance Project—Africa. 

9. Finance Project—Sub-Saharan Africa. 

10. Finance Project—Mexico/Latin America. 

11. Finance Project—Asia and the Pacific Islands. 

12. Approval of March 21, 2008 Minutes (Closed Portion). 

13. Approval of April 17, 2008 Minutes (Closed Portion). 

14. Pending Major Projects. 

15. Reports. 

# FOR FURTHER INFORMATION CONTACT:

Information on the meeting may be obtained from Connie M. Downs at (202) 336-8438. 

Dated: July 2, 2008. 

Connie M. Downs, 

Corporate Secretary, Overseas Private Investment Corporation.

[FR Doc. 08-1416 Filed 7-2-08; 12:21 pm] 

BILLING CODE 3210-01-P
### UNPUBLISHED



# UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT



#  U NITED S TATES OFA MERICA ,

Plaintiff-Appellee,

v. No. 03-4042



# 
T RACY C ALVIND UNLAP , J R .,

Defendant-Appellant. 

# 
Appeal from the United States District Court for the Middle District of North Carolina, at Durham.

William L. Osteen, District Judge.

(CR-02-165) Submitted: October 22, 2003 Decided: November 13, 2003 Before WIDENER, WILLIAMS, and KING, Circuit Judges.

Affirmed by unpublished per curiam opinion.

COUNSELTracy Calvin Dunlap, Jr., Appellant Pro Se. Douglas Cannon, Assistant United States Attorney, Greensboro, North Carolina, for Appellee.

Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).OPINION
PER CURIAM: Tracy Calvin Dunlap, Jr., was convicted of numerous fraud and related charges and sentenced to 324 months of imprisonment as a result of his participation in a scheme to defraud investors. Dunlap is proceeding pro se and raises four issues on appeal. For the reasons that follow, we affirm.First, Dunlap has failed to show that his indictment was constructively amended in violation of the Fifth Amendment. United States v. Floresca , 38 F.3d 706, 710 (4th Cir. 1994). To the extent that Dunlap now objects to evidence of the "Tonda Mesa" account being admitted at trial, we do not find that the district court plainly erred in allowing its admission. Fed. R. Crim. P. 52(b); United States v. Olano , 507 U.S. 725, 733-37 (1993). Second, Dunlap alleges certain anomalies regarding the grand jury proceedings. Our review of the record does not disclose any prejudice to Dunlap. Bank of Nova Scotia v. United States , 487 U.S. 250, 256-57 (1988). Neither does our review show constitutional error or prosecutorial misconduct. United States v. Mills , 995 F.2d 480, 486 (4th Cir. 1993). Accordingly, this claim fails.Next, we do not find that the district court clearly abused its discretion by denying Dunlap’s motion for a bill of particulars. United States v. Jackson , 757 F.2d 1486, 1491 (4th Cir. 1985). Finally, we find that Dunlap failed to establish grounds for the district judge to recuse himself from conducting the trial. Shaw v. Martin , 733 F.2d 304, 308 (4th Cir. 1984). The district court did not abuse its discretion by denying Dunlap’s motion to recuse. United States v. DeTemple , 162 F.3d 279, 283 (4th Cir. 1998). Accordingly, we affirm Dunlap’s convictions and sentence. We dispense with oral argument because the facts and legal contentionsare adequately presented in the materials before the court and argument would not aid the decisional process.
AFFIRMED 2 U NITED S TATES v. D UNLAP
#### Anthony S. Garges *v.*State Compensation Commissioner, *et al.*

(No. 12134)

Submitted on Rehearing May 29, 1962.

Decided February 13, 1962.

Decided on Rehearing June 26, 1962.

Berry, Judge, dissenting.

*Mahan, Higgins, Thrift & Graney, Patrick*C. *Graney, Jr.,*for appellant.

*R. L. Theibert,*for appellee.

Calhoun, President:

This case was decided by the Court on February 13, 1962, the opinion being reported in 123 S. E. 2d 886, to which opinion reference is made for a statement of pertinent facts.

On May 1,1962, the Court granted a rehearing in this case and also in the case of *Turner*v. *State Compensation Commissioner, et al.,*the original opinion therein being reported in 123 S. E. 2d 880; and both cases were again submitted for decision on written briefs and oral arguments of counsel for the respective parties.

The original decision in the instant case is, on this rehearing, now adhered to for reasons stated in the opinion filed simultaneously herewith on rehearing in the case of *Turner*v. *State Compensation Commissioner et al.*

*Reversed and remanded.*

*189Berry, Judge,

dissenting:

I dissent from the majority opinion in the rehearing of this case for the reasons stated in the dissenting opinion filed in the case of *Turner*v. *State Compensation Commissioner and New River and Pocahontas Consolidated Coal Company,*decided on rehearing at this term of Court.
# Fourth Court of Appeals San Antonio, Texas

July 1, 2019

No. 04

- 18

- 00822

- CR

J ake Eric ALVARADO, Appellant

v.

Th e STATE of Texas, Appellee

From the 38th Judicial District Court, Medina County, Texas

Trial Court No. 16

- 05

- 11980

- CR Honorable Camile Glasscock Dubose, Judge Presiding



### O R D E R

The State’s brief was originally due to be filed on March 28, 2019. On April 1, 2019, the State filed a motion for extension of time to file its brief requesting a 90

- day extension of the deadline. By order dated April 3, 2019, this court granted the motion; however, our order stated,

“ Given the length of the extension, THIS IS THE FINAL EXTENSION OF TIME THAT THE STATE WILL BE GRANTED

. ”

On June 26, 2019, the State filed a second motion for extension of time to file its brief based on two recent deaths in the immediate family of the attorney representing the State. The motion is GRANTED; however, given the length of the extensions granted to date, THIS IS THE FINAL EXTENSION OF TIME THAT THE STATE WIL L BE GRANTED . The State’s brief must be filed no later than July 26, 2019.

_________________________________ Sandee Bryan Marion, Chief Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said court on this 1st day of July, 2019

.

___________________________________ KEITH E. HOTTLE

, Clerk of Court
[Federal Register Volume 73, Number 17 (Friday, January 25, 2008)]
[Rules and Regulations]
[Page 4449]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-208]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 71

[Docket No. FAA-2005-22493; Airspace Docket No. 05-AEA-021]


Amendment of Class E Airspace; Philipsburg, PA

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule; confirmation of effective date.

-----------------------------------------------------------------------

SUMMARY: This action confirms the effective date of a direct final rule 
that amends a Class E airspace area to support Area Navigation (RNAV) 
Global Positioning System (GPS) Special Instrument Approach Procedures 
(IAPs) that serve the Philipsburg Area Hospital, Philipsburg, PA.

DATES: Effective 0901 UTC, December 20, 2007. The Director of the 
Federal Register approves this incorporation by reference action under 
Title 1, Code of Federal Regulations, part 51, subject to the annual 
revision of FAA Order 7400.9 and publication of conforming amendments.

FOR FURTHER INFORMATION CONTACT: Daryl Daniels, Airspace Specialist, 
System Support, AJO2-E2B.12, FAA Eastern Service Center, 1701 Columbia 
Ave., College Park, GA 30337; telephone (404) 305-5581; fax (404) 305-
5572.

SUPPLEMENTARY INFORMATION:

Confirmation of Effective Date

    The FAA published this direct final rule with a request for 
comments in the Federal Register on November 2, 2007 (72 FR 62110-
62111). The FAA uses the direct final rulemaking procedure for a non 
controversial rule where the FAA believes that there will be no adverse 
public comment. This direct final rule advised the public that no 
adverse comments were anticipated, and that unless a written adverse 
comment, or a written notice of intent to submit such an adverse 
comment, were received within the comment period, the regulation would 
become effective on December 20, 2007. No adverse comments were 
received, and thus this notice confirms that effective date.

    Issued in College Park, GA on December 17, 2007.
Mark D. Ward,
Manager, System Support Group, Eastern Service Center.
[FR Doc. 08-208 Filed 1-24-08; 8:45 am]
BILLING CODE 4910-13-M
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

January 29, 2007 Clifford W. Taylor, Chief Justice

132350 Michael F. Cavanagh
Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan Robert P. Young, Jr. JEANNE CORNELL and DAVID EDWARD Stephen J. Markman, CORNELL, Justices Plaintiffs-Appellees,

v SC: 132350 COA: 269331 Washtenaw CC: 03-001028-NO ERP OPERATING LIMI TED PARTNERSHIP and EQUITY RESIDENTIAL PROPERTY MANAGEMENT CORPORATION, Defendants-Appellants, and

PINES OF CLOVERLANE APARTMENTS, Defendant.

________________ _______________ __________/

On order of the Court, the application fo r leave to appeal the September 19, 2006 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the questions pr esented should be reviewed by this Court prior to the completion of the proceedings or dered by the Court of Appeals.

t0122 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

January 29, 2007

Clerk
[Federal Register Volume 73, Number 26 (Thursday, February 7, 2008)]
[Notices]
[Page 7311]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-520]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Human Genome Research Institute 
Special Emphasis Panel, T32 Application.
    Date: March 6, 2008.
    Time: 12 p.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5635 Fishers Lane, 
Bethesda, MD 20892. (Telephone Conference Call)
    Contact Person: Rudy O. Pozzatti, PhD, Scientific Review 
Officer, Scientific Review Branch, National Human Genome Research 
Institute, 5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD 
20852, (301) 402-0838, <a href="/cdn-cgi/l/email-protection#35455a4f4f544141477558545c591b5b5c5d1b525a43"><span class="__cf_email__" data-cfemail="8efee1f4f4effafafccee3efe7e2a0e0e7e6a0e9e1f8">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Nos. 93.172, Human Genome 
Research, National Institutes of Health, HHS)

    January 31, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-520 Filed 2-6-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 (AS ADOPTED


PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)





In connection with the annual report of One eCommerce Corporation (the “Company”) on Form 10-Q for the period ending June 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Welch, Principal Executive Officer, certify to my knowledge and in my capacity as an officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and,


2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.


Date: August 12, 2010/s/ John WelchJohn WelchPrincipal Executive Officer A certification furnished pursuant to this Item will not be deemed “filed” for purposes of section 18 of the Exchange Act (15 U.S.C. 78r), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the small business issuer specifically incorporates it by reference.
115TH CONGRESS 

2D SESSION H. R. 5729 

AN ACT 

To restrict the department in which the Coast Guard is 

operating from implementing any rule requiring the use 

of biometric readers for biometric transportation security 

cards until after submission to Congress of the results 

of an assessment of the effectiveness of the transportation security card program. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 5729 EH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Transportation Worker 

3 Identification Credential Accountability Act of 2018’’. 

4 SEC. 2. RESTRICTION ON IMPLEMENTATION OF TRANSPOR5 TATION WORKER IDENTIFICATION CREDEN6 TIAL BIOMETRIC READER RULE. 

7 The department in which the Coast Guard is oper8 ating may not implement the rule entitled ‘‘Transpor9 tation Worker Identification Credential (TWIC)–Reader 

10 Requirements’’ (81 Fed. Reg. 57651), and may not pro11 pose or issue a notice of proposed rulemaking for any revi12 sion to such rule except to extend its effective date, or 

13 for any other rule requiring the use of biometric readers 

14 for biometric transportation security cards under section 

15 70105(k)(3) of title 46, United States Code, before the 

16 end of the 60-day period beginning on the date of the sub17 mission under paragraph (5) of section 1(b) of Public Law 

18 114–278 (130 Stat. 1411 to 1412) of the results of the 

19 assessment required by that section. 

20 SEC. 3. PROGRESS UPDATES. 

21 Not later than 30 days after the date of the enact22 ment of this Act, and every 90 days thereafter until the 

23 submission under paragraph (5) of section 1(b) of Public 

24 Law 114–278 (130 Stat. 1411 et seq.) of the results of 

25 the assessment required by that section, the Secretary of 

26 Homeland Security shall report to the Committee on 
3 

•HR 5729 EH

1 Homeland Security and the Committee on Transportation 

2 and Infrastructure of the House of Representatives and 

3 the Committee on Commerce, Science, and Transportation 

4 of the Senate regarding the implementation of that sec5 tion. 

Passed the House of Representatives July 10, 2018. 

Attest: 

Clerk. 
115TH CONGRESS 

2D SESSION H. R. 5729 

AN ACT 

To restrict the department in which the Coast 

security card program. ment of the effectiveness of the transportation mission to Congress of the results of an assessric transportation security cards until after subrequiring the use of biometric readers for biometGuard is operating from implementing any rule
I 

115TH CONGRESS 

2D SESSION H. R. 5712 

To amend title XIX of the Social Security Act to compel manufacturers 

to correct inaccurate classification data reported to the Medicaid rebate 

program, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 8, 2018 

Mr. SCHRADER (for himself and Mr. WELCH) introduced the following bill; 

which was referred to the Committee on Energy and Commerce 

A BILL 

To amend title XIX of the Social Security Act to compel 

manufacturers to correct inaccurate classification data 

reported to the Medicaid rebate program, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Medicaid Drug Rebate 

5 Accountability Act’’. 


lotter on DSKBCFDHB2PROD with BILLS
2 

•HR 5712 IH

1 SEC. 2. AUTHORITY TO COMPEL MANUFACTURERS TO COR2 RECT INACCURATE CLASSIFICATION DATA 

3 REPORTED TO MEDICAID REBATE PROGRAM. 

4 Section 1927(b)(3) of the Social Security Act (42 

5 U.S.C. 1396r–8(b)(3)) is amended by adding at the end 

6 the following new subparagraph: 

7 ‘‘(E) REMEDY WITH RESPECT TO INAC8 CURATE CLASSIFICATION DATA.— 

9 ‘‘(i) CORRECTION OF INACCURATE

10 CLASSIFICATION DATA.—In the case that 

11 the Secretary determines that drug classi12 fication data reported on or after Sep13 tember 30, 2018, by a manufacturer under 

14 this paragraph, with respect to a covered 

15 outpatient drug of such manufacturer, pro16 vides an inaccurate classification for such 

17 drug, the Secretary shall require such 

18 manufacturer to correct, within a 30-day 

19 period, the classification for such drug. 

20 ‘‘(ii) CIVIL MONETARY PENALTY.—In 

21 the case of a manufacturer who fails to 

22 correct the classification of a covered out23 patient drug within a 30-day period pursu24 ant to clause (i), the Secretary shall, be25 ginning the day after the end of such 30- 

26 day period, require such manufacturer to 


lotter on DSKBCFDHB2PROD with BILLS
3 

•HR 5712 IH

1 pay a civil monetary penalty of $100,000 

2 per day until the date on which the manu3 facturer corrects such classification. 

4 ‘‘(iii) CLASSIFICATION DEFINED.— 

5 For purposes of this subparagraph, the 

6 term ‘classification’ means identification or 

7 designation as one of the following: 

8 ‘‘(I) A single source drug. 

9 ‘‘(II) An innovator multiple 

10 source drug. 

11 ‘‘(III) A noninnovator multiple 

12 source drug.’’. 

Æ 


lotter on DSKBCFDHB2PROD with BILLS